Patient, People, Process: The 3 P’s to bring the best of breed clinical research
Empowering Patient Diversity
Clinear Research strategically connects Europe and Africa passing through Mauritius and Réunion Islands, fostering diversity in clinical trials to drive unparalleled business success.
Our People
Our adept team excels in managing intricate international clinical research studies, skillfully leveraging our expertise and values to seamlessly bridge the gap between the industry, a wide spectrum of patients, and global research sites, fostering a healthier world.
Our Process
“We are what we repeatedly do. Excellence then, is not an act, but a habit” —Aristotle
Services
We provide an end-to-end solution tailored to the clinical trial need of the client
Clinical Operation
Services
Providing Complete Trial Management Services tailored made to your clinical trial need and global expansion
Site Management
Organistion
Providing effective support to the Investigators and his collaborators
Remote Management &
Risk Based Monitoring
Trending to a new norm:From on-site to Remote management and monitoring
Who we've worked with
Meet Our CEO
Lutchmee Nobaub
Lutchmee Nobaub completed her higher education at the Paris XII university , in science, health, and application. She has more than 16 years experience in clinical research, accumulating, through different positions, experiences, and contacts throughout Western Europe. After ten years of working for the top 4 CROs, she founded Clinear Research where she managed more than 30 studies in Mauritius, Réunion, Islands, and western Europe.
This adventure allowed her to learn new aspects of her profession, as a business manager, and to diversify her skills. The necessary adaptation to a very different local reality allowed her to find the means to combine international requirements and local specificities and regulations.
Since 2021, she has received several awards including Health Revelation at Women In Africa Initiative, Laureate WIA54 2021 and Africa’s most respected CEO award 2022.
Participating in the progress of medicine and the care of patients particularly the pan-African population has been her main motivation. She strongly believes in a personalized medicine tailored to the patient’ interest and genetic diversity.